COVID-19 reinfection after pregnancy.
COVID-19
Pregnancy
Reinfection
Journal
Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
27
09
2021
revised:
24
12
2021
accepted:
10
01
2022
pubmed:
23
1
2022
medline:
4
3
2022
entrez:
22
1
2022
Statut:
ppublish
Résumé
There have been reports of COVID-19 reinfections, but the immunological characterization of these cases is partial. We report a case of reinfection with SARS-CoV-2, where the first infection occurred in the course of late pregnancy. On May 27, 2020, a 37-year-old woman gave birth at full term, 3 hours after full dilatation. She developed fever (38.3°C) after delivery. Mild biological anomalies compatible with COVID-19 were observed: lymphopenia, thrombocytopenia, elevated D-Dimers, CRP, and LDH. At 6-month follow-up, she reported having contracted COVID-19 with high fever, rhinorrhea, hand frostbites, cough, headache, dysgeusia and anosmia. We report a case of COVID-19 reinfection with a first mild infection during late pregnancy and a more aggressive second infection 5 months later.
Sections du résumé
BACKGROUND
BACKGROUND
There have been reports of COVID-19 reinfections, but the immunological characterization of these cases is partial. We report a case of reinfection with SARS-CoV-2, where the first infection occurred in the course of late pregnancy.
CASE PRESENTATION
METHODS
On May 27, 2020, a 37-year-old woman gave birth at full term, 3 hours after full dilatation. She developed fever (38.3°C) after delivery. Mild biological anomalies compatible with COVID-19 were observed: lymphopenia, thrombocytopenia, elevated D-Dimers, CRP, and LDH. At 6-month follow-up, she reported having contracted COVID-19 with high fever, rhinorrhea, hand frostbites, cough, headache, dysgeusia and anosmia.
CONCLUSIONS
CONCLUSIONS
We report a case of COVID-19 reinfection with a first mild infection during late pregnancy and a more aggressive second infection 5 months later.
Identifiants
pubmed: 35065269
pii: S2666-9919(22)00002-1
doi: 10.1016/j.idnow.2022.01.002
pmc: PMC8769937
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-103Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.
Références
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101826
pubmed: 32505805
Front Immunol. 2020 Jul 07;11:1672
pubmed: 32733490
J Med Virol. 2021 Apr;93(4):1857-1859
pubmed: 33112002
R I Med J (2013). 2020 Nov 9;103(10):24-26
pubmed: 33172223
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
Tissue Antigens. 2013 Mar;81(3):127-36
pubmed: 23347068
J Gynecol Obstet Hum Reprod. 2021 Sep;50(7):102041
pubmed: 33310133
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):565-574
pubmed: 33006691
J Clin Immunol. 2021 Feb;41(2):303-314
pubmed: 33188624
J Med Virol. 2020 Sep;92(9):1660-1664
pubmed: 32330313
Int J Infect Dis. 2020 Apr;93:297-299
pubmed: 32147538
Facts Views Vis Obgyn. 2019 Sep;11(3):243-250
pubmed: 32082531
Lancet Public Health. 2021 May;6(5):e335-e345
pubmed: 33857453
BMC Pregnancy Childbirth. 2014 Nov 19;14:384
pubmed: 25406658
BMJ Evid Based Med. 2021 Jun;26(3):107-108
pubmed: 32934000
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:559-562
pubmed: 32732059
Rev Med Virol. 2021 Sep;31(5):1-16
pubmed: 33387448
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Blood. 2008 May 15;111(10):4862-70
pubmed: 18334671